GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (FRA:VP2) » Definitions » Other Long Term Assets

Valeo Pharma (FRA:VP2) Other Long Term Assets : €0.00 Mil (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Valeo Pharma Other Long Term Assets?

Valeo Pharma's other long-term assets for the quarter that ended in Jan. 2024 was €0.00 Mil.

Valeo Pharma's quarterly other long-term assets declined from Jul. 2023 (€-0.00 Mil) to Oct. 2023 (€-0.00 Mil) but then increased from Oct. 2023 (€-0.00 Mil) to Jan. 2024 (€0.00 Mil).

Valeo Pharma's annual other long-term assets increased from Oct. 2021 (€0.00 Mil) to Oct. 2022 (€0.00 Mil) but then declined from Oct. 2022 (€0.00 Mil) to Oct. 2023 (€-0.00 Mil).


Valeo Pharma Other Long Term Assets Historical Data

The historical data trend for Valeo Pharma's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Other Long Term Assets Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Other Long Term Assets
Get a 7-Day Free Trial - - - - -

Valeo Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Valeo Pharma Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Valeo Pharma (FRA:VP2) Business Description

Traded in Other Exchanges
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Valeo Pharma (FRA:VP2) Headlines

No Headlines